1-9 of 9
Ji Ma
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Interim Report of Bendamustine Plus Rituximab As First-Line Induction Therapy with or without Lenalidomide Maintenance Therapy in Chinese Patients with Indolent Non-Hodgkin's Lymphoma or Elderly Mantle Cell Lymphoma: Data from a Multi-Center Prospective Trial

Hui Wang, Qiang He, Rongrong Zhao, Linna Xie, Ji Ma, Cong Liu, Ke Lu, Haichen Wei, Dan Liu, Lijie Xing, Xiuzhi Deng, Zhongliang Sun, Xiaoxia Chu, Na Gao, Yuping Zhong, Yanhua Sun, Haiyan Zhang, Hao Zhang, Wenwei Xu, Zengjun Li
Journal: Blood
Blood (2022) 140 (Supplement 1): 11962–11963.
https://doi.org/10.1182/blood-2022-162507
Published: 2022
Journal Articles

A Multicenter, Single-Arm, Prospective Phase II Study of Orelabrutinib Combined with High-Dose Methotrexate and Rituximab Sequential Autologous Hematopoietic Stem Cell Transplantation in Newly-Dignosed Primary Central Nervous System Lymphoma

Ji Ma, Qiang He, Ke Lu, Liang Wang
Journal: Blood
Blood (2022) 140 (Supplement 1): 3744–3745.
https://doi.org/10.1182/blood-2022-165720
Published: 2022
Journal Articles

Untargeted Metabolomics of Cerebrospinal Fluid in Patients with Primary Central Nervous System Lymphoma

Xiaoyue Wang, Ji Ma, Liang Wang
Journal: Blood
Blood (2022) 140 (Supplement 1): 11921–11922.
https://doi.org/10.1182/blood-2022-162899
Published: 2022
Journal Articles

Zanubrutinib PLUS RCHOP(ZR-CHOP) Regimen Achieves High Complete Response Rate in the Treatment of Newly-Diagnosed Double-Expression Diffuse Large B Cell Lymphoma

Qiang He, Linna Xie, Rongrong Zhao, Ji Ma, Hui Wang, Jie Li, Chuanli Zhao, Y. Lynn Wang, Zengjun Li
Journal: Blood
Blood (2022) 140 (Supplement 1): 6614–6615.
https://doi.org/10.1182/blood-2022-168859
Published: 2022
Journal Articles

SHP1 Loss Augments DLBCL Cellular Response to Ibrutinib: A Candidate Predictive Biomarker

Y. Lynn Wang, Ji Ma, Vinay Mallikarjuna, Pin Lu, Shengchun Wang, Sahar Poureghbali, Mariusz A Wasik, Reza Nejati, Wenjun Wu
Journal: Blood
Blood (2021) 138 (Supplement 1): 3490.
https://doi.org/10.1182/blood-2021-146086
Published: 2021
Journal Articles

Cladribine, Cytarabine, Granulocyte Colony Stimulating Factor ± Mitoxantrone (CLAG ± M) Is Highly Effective Therapy for Secondary and Relapsed/Refractory Acute Myeloid Leukemia

Amanda Przespolewski, DO, Craig W. Freyer, PharmD, Wenyan Ji, MA, Tara L. Cronin, BA, Swapna Thota, MD, Elizabeth A. Griffiths, MD, James E. Thompson, MD, Amro Elshoury, MBBChir, Jeffrey Baron, PharmD, Mark Walsh, PharmD, Eunice S. Wang, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1361.
https://doi.org/10.1182/blood-2019-130582
Published: 2019
Journal Articles

Human Leukocyte Antigen-G Restores Immune Tolerance in Immune Thrombocytopenia

Qi Feng, Ji Ma, Xin Li, Ming Hou, Jun Peng, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3751.
https://doi.org/10.1182/blood-2018-99-115713
Published: 2018
Journal Articles

High-dose dexamethasone corrects impaired myeloid-derived suppressor cell function via Ets1 in immune thrombocytopenia

Yu Hou, Qi Feng, Miao Xu, Guo-sheng Li, Xue-na Liu, Zi Sheng, Hai Zhou, Ji Ma, Yu Wei, Yuan-xin Sun, Ying-yi Yu, Ji-hua Qiu, Lin-lin Shao, Xin-guang Liu, Ming Hou, Jun Peng
Journal: Blood
Blood (2016) 127 (12): 1587–1597.
https://doi.org/10.1182/blood-2015-10-674531
Published: 2016
Includes: Supplemental data
Journal Articles

Thalidomide corrects impaired mesenchymal stem cell function in inducing tolerogenic DCs in patients with immune thrombocytopenia

Ji Ma, Yun-na Ning, Miao Xu, Yu Hou, Ning Wang, Xiao-yan Hou, Ying-yi Yu, Hui Li, Wei-dong He, Lin-lin Shao, Hai Zhou, Ya-nan Min, Xin-guang Liu, Yan Shi, Ping Qin, Cheng-shan Guo, Ming Hou, Jun Peng
Journal: Blood
Blood (2013) 122 (12): 2074–2082.
https://doi.org/10.1182/blood-2013-03-491555
Published: 2013